Get started
Author

Sunilkumar Kakadia

Observed names: Sunil Kakadia, Sunil Kumar Kakadia, SunilKumar Kakadia
Institution: CHI St. Vincent
ORCID: 0000-0002-3312-1605
Observed ORCID: 0000-0002-3312-1605
OpenAlex ID: A5090286841
Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma
2018 · Sunilkumar Kakadia, Naveen Yarlagadda, et al. · OncoTargets and Therapy · 293
PDF
Integrating artificial intelligence with circulating tumor DNA for non-small cell lung cancer: opportunities, challenges, and future directions
2025 · Nishanth Thalambedu, Mamtha Balla, et al. · Frontiers in Medicine · 20
PDF
Immunotherapy Outcomes in Advanced Melanoma in Relation to Age
2020 · Krishna Joshi, Dinesh Atwal, et al. · The Permanente Journal · 15
Scurvy in the Modern World: Extinct or Not?
2022 · FNU Amisha, Sai Nikhila Ghanta, et al. · Cureus · 11
PDF
Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
2022 · Meera Mohan, Sravani Gundarlapalli, et al. · American Journal of Hematology · 6
Acquired Hyperzincaemia Due to Zinc-Laden Denture Adhesives Leading to Hypocupraemia as a Cause of Neutropenia
2021 · FNU Amisha, Prachi Saluja, et al. · European Journal of Case Reports in Internal Medicine · 5
PDF
Choroidal Metastasis as the Initial Presentation of Rectal Adenocarcinoma
2021 · FNU Amisha, Tanvi Harishbhai Patel, et al. · European Journal of Case Reports in Internal Medicine · 4
PDF
Epidemiology of Aggressive NK-Cell Leukemia in the United States: A SEER Population-Based Study
2021 · Fnu Amisha, Paras Malik, et al. · Blood · 4
The Association of “GOOP” on Gross Examination of Fine Needle Aspiration Samples and On-Site Adequacy
2021 · Nikhil Meena, Thaddeus Bartter, et al. · Respiration · 4
Early Outcomes of Ruxolitinib in the Treatment of Steroid Refractory Graft-versus-host Disease on Liver Transplant Recipients
2020 · Sunilkumar Kakadia, Holly Trotta, et al. · Transplantation · 4
Eight-Color Flow Cytometry Phenotypic Markers and Disease Progression in Monoclonal Gammopathy of Unknown Significance
2021 · Naveen K Yarlagadda, Meera Mohan, et al. · Blood · 1
Long‐Term Durability and Safety Signals of Systemic AAV Gene Therapy for Haemophilia A and B: A Systematic Review
2026 · Mahboob Younus Shaik, Jay Patel, et al. · European Journal Of Haematology
PDF
Venetoclax‐Based Regimens in Newly Diagnosed FLT3‐Mutated Older or Unfit Acute Myeloid Leukemia: A Systematic Review and Meta‐Analysis of Comparative and Single‐Arm Outcomes
2026 · Mahboob Younus Shaik, Jay Patel, et al. · Hematological Oncology
PDF
AML-454: Persistent DNMT3A Mutations Predicting Relapse After Acute Myeloid Leukemia Remission: A Systematic Review of Molecular Persistence and Circulating DNA Dynamics
2026 · Mahboob Younus Shaik, Taha Hassan, et al. · Clinical Lymphoma Myeloma & Leukemia
MM-453: Durability of Response, Mechanisms of Resistance, and Retreatment Outcomes Following CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma: A Systematic Review
2026 · Mahboob Younus Shaik, Sahar Amjad, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: AML-454: Persistent DNMT3A Mutations Predicting Relapse After Acute Myeloid Leukemia Remission: A Systematic Review of Molecular Persistence and Circulating DNA Dynamics
2026 · Mahboob Younus Shaik, Taha Hassan, et al. · Clinical Lymphoma Myeloma & Leukemia
Geographical distribution of prostate cancer clinical trials across the United States.
2022 · Fnu Amisha, Sunny R K Singh, et al. · Journal of Clinical Oncology
Tandem Autologous Stem Cell Transplantation in Patients with Persistent Bone Marrow Minimal Residual Disease Post First Transplantation in Multiple Myeloma
2022 · Meera Mohan, Sravani Gundarlapalli, et al. · Transplantation and Cellular Therapy
Analysis of Hematopoietic Niche Components Post Allogeneic Transplantation
2021 · Aasiya Matin, Sunil Kakadia, et al. · Blood
Clinical Outcome of Refractory Lymphoma Patients with Non Response to Chimeric Antigen Receptor T Cell Therapy
2021 · Fnu Amisha, Sunilkumar Kakadia, et al. · Blood
Improved Clinical Outcome with Busulfan Based Conditioning Using Peripheral Blood T Cell Replete Allogenic Stem Cell Transplantation (alloSCT) with Post Transplant Cyclophosphamide (PTCy) Based GVHD Prophylaxis: A Single Center Experience
2021 · Akash Mukherjee, Aasiya Matin, et al. · Transplantation and Cellular Therapy
Works count: 21
Citation count: 365
H-index: 5
I10-index: 4
Year
Topic
Type